Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FTXFQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,269
Award facts
- Contract value 100% obligated
- $14,268.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,268.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Wegovy 1.7 mg/0.75 mL pen injectors with an ultimate completion date of July 14, 2025. This non-set-aside competitive award was issued on July 11, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills diverse pharmaceutical supply needs for the Defense Health Agency and military healthcare programs through the DLA Medical Supply Chain. The company's established track record demonstrates consistent capability to deliver brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains through competitively awarded contracts with firm fixed pricing. This Wegovy delivery order exemplifies AmerisourceBergen's role in supporting military personnel and veteran healthcare through the DLA's pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FTXFQ?
SPE2DB25FTXFQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 11, 2025.
How much is contract SPE2DB25FTXFQ worth?
The government has obligated $14,269 on SPE2DB25FTXFQ.
Is contract SPE2DB25FTXFQ an order under another contract?
Yes. SPE2DB25FTXFQ is a delivery order under SPE2DB25D7068, an indefinite delivery contract.
Was contract SPE2DB25FTXFQ competed?
The extent of competition for SPE2DB25FTXFQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award